提示: 手机请竖屏浏览!

病例21-2017:一名患宫颈内癌的28岁孕妇
Case 21-2017 — A 28-Year-Old Pregnant Woman with Endocervical Carcinoma


ohn O. Schorge ... 肿瘤 妇产科和儿科 • 2017.07.13
相关阅读
• 利用人乳头瘤病毒及细胞学联合检测进行宫颈癌的筛查 • 贝伐珠单抗改善晚期宫颈癌患者的生存情况

病历陈述


Mariam Naqvi医师(妇产科):一名28岁患有Rh同种免疫和宫颈内癌的妊娠妇女,在孕34.1周时来本院母胎门诊就诊。

患者孕3,2001年曾产活婴(之前第一次分娩为足月死胎)。在另外一个州的当地医院进行本次妊娠的第一次产前检查时,她自述阴道有点滴出血。查体发现质脆、息肉样肿块(直径2 cm)自子宫颈突出。超声检查显示孕龄为9周5日。除超声以外,患者拒绝胎儿非整倍体的筛查试验和其他胎儿评估方法。检测出不规则抗体并经鉴定为抗D抗体,其滴度为1∶1。被转诊去看当地的产科医师。双合诊检查发现病灶(直径2 cm)已经延伸至宫颈管。遂对子宫颈做活组织检查。





作者信息

ohn O. Schorge, M.D., Andrea L. Russo, M.D., Michael F. Greene, M.D., Melissa A. Woythaler, M.D., and Esther Oliva, M.D.
From the Departments of Obstetrics and Gynecology (J.O.S., M.F.G.), Radiation Oncology (A.L.R.), Pediatrics (M.A.W.), and Pathology (E.O.), Massachusetts General Hospital, and the Departments of Obstetrics, Gynecology, and Reproductive Biology (J.O.S., M.F.G.), Radiation Oncology (A.L.R.), Pediatrics (M.A.W.), and Pathology (E.O.), Harvard Medical School — both in Boston.

 

参考文献

1. Galic V, Herzog TJ, Lewin SN, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 2012;125:287-291

2. Ruba S, Schoolland M, Allpress S, Sterrett G. Adenocarcinoma in situ of the uterine cervix: screening and diagnostic errors in Papanicolaou smears. Cancer 2004;102:280-287

3. Ursin G, Peters RK, Henderson BE, d’Ablaing G III, Monroe KR, Pike MC. Oral contraceptive use and adenocarcinoma of cervix. Lancet 1994;344:1390-1394

4. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-540

5. Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer, version 2.2015. J Natl Compr Canc Netw 2015;13:395-404

6. Bogani G, Cromi A, Uccella S, et al. Laparoscopic versus open abdominal management of cervical cancer: long-term results from a propensity-matched analysis. J Minim Invasive Gynecol 2014;21:857-862

7. Schorge JO, Lee KR, Lee SJ, Flynn CE, Goodman A, Sheets EE. Early cervical adenocarcinoma: selection criteria for radical surgery. Obstet Gynecol 1999;94:386-390

8. Tewari K, Cappuccini F, Gambino A, Kohler MF, Pecorelli S, DiSaia PJ. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer 1998;82:1529-1534

9. Sood AK, Sorosky JI, Mayr N, Anderson B, Buller RE, Niebyl J. Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes. Obstet Gynecol 2000;95:832-838

10. Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000;342:9-14

11. Liley AW. Liquor amnil analysis in the management of the pregnancy complicated by resus sensitization. Am J Obstet Gynecol 1961;82:1359-1370

12. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IAG. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803

13. Walker JL, Powell CB, Chen LM, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer 2015;121:2108-2120

14. Chen J, Wang R, Zhang B, et al. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis. Am J Obstet Gynecol 2016;215:460.e1-460.e13

15. Wilbur D, Colgan T, Ferenczy A, et al. Tumours of the uterine cervix: epithelial tumours — glandular tumours and precursors. In: Kurman RJ, Carcangiu M, Herrington S, Young RH, eds. World Health Organization classification of tumours of female reproductive organs. 4th ed. Lyon, France: IARC Press, 2014:183-184.

16. Ronnett BM. Endocervical adenocarcinoma: selected diagnostic challenges. Mod Pathol 2016;29:Suppl 1:S12-S28

17. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002;41:185-207

18. Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000;157:1055-1062

19. Bishop JA, Lewis JS Jr, Rocco JW, Faquin WC. HPV-related squamous cell carcinoma of the head and neck: an update on testing in routine pathology practice. Semin Diagn Pathol 2015;32:344-351

20. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284

21. Kusanagi Y, Kojima A, Mikami Y, et al. Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype. Am J Pathol 2010;177:2169-2175

22. Meserve EE, Nucci MR. Peutz-Jeghers syndrome: pathobiology, pathologic manifestations, and suggestions for recommending genetic testing in pathology reports. Surg Pathol Clin 2016;9:243-268

23. Mikami Y, McCluggage WG. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol 2013;20:227-237

24. Keir A, Agpalo M, Lieberman L, Callum J. How to use: the direct antiglobulin test in newborns. Arch Dis Child Educ Pract Ed 2015;100:198-203

25. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 2004;144:626-631

26. Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn: postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med 2008;13:265-271

27. Maisels M, Baltz RD, Bhutanu VK, et al. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316

28. Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 2011;127:315-323

29. Fischer GW. Therapeutic uses of intravenous gammaglobulin for pediatric infections. Pediatr Clin North Am 1988;35:517-533

30. Corvaglia L, Legnani E, Galletti S, Arcuri S, Aceti A, Faldella G. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease. J Matern Fetal Neonatal Med 2012;25:2782-2785

31. Figueras-Aloy J, Rodríguez-Miguélez JM, Iriondo-Sanz M, Salvia-Roiges MD, Botet-Mussons F, Carbonell-Estrany X. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics 2010;125:139-144

32. Clinical practice guidelines in oncology: cervical cancer, version 1.2016. Fort Washington, PA: National Comprehensive Cancer Network, 2016 (http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf).

33. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol 1999;73:177-183

34. Peters WA III, Liu PY, Barrett RJ II, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613

服务条款 | 隐私政策 | 联系我们